NCT05452382View on ClinicalTrials.gov

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

2,607

Participants

Timeline

Start Date

January 1, 2005

Primary Completion Date

December 30, 2019

Study Completion Date

July 6, 2022

Conditions
Appendiceal Cancer
Interventions
PROCEDURE

Partial colecctomy

Segmental resection of appendiceal adenocarcinoma including terminal ileum and cecum

PROCEDURE

Hemicolectomy

Formal right hemicolectomy including terminal ileum, cecum, and ascending colon

Trial Locations (1)

33331

Cleveland Clinic Flroida, Weston

All Listed Sponsors
collaborator

Cleveland Clinic Florida

OTHER

lead

Mansoura University

OTHER

NCT05452382 - Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma | Biotech Hunter | Biotech Hunter